Data Foundry

Drug recalls 2015

Amlodipine besylate and Atorvastatin calcium Tablets — Class III drug recall D-1377-2015

Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2015-09-02, distributed nationwide. Subpotent Drug: Subpotent atorvastatin.

Recall numberD-1377-2015
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDr. Reddy's Laboratories, Inc., Princeton, NJ, United States
Recall initiated2015-08-13
Classified2015-08-27
Reported by FDA2015-09-02
Terminated2016-12-15
DistributedNationwide (US)
Reason classespotency
NDC43598-0313, 43598-0313-05, 43598-0313-30, 43598-0313-60, 43598-0313-90, 43598-0314, 43598-0314-05, 43598-0314-30, 43598-0314-60, 43598-0314-90, 43598-0315, 43598-0315-05, 43598-0315-30, 43598-0315-60, 43598-0315-90, 43598-0316, 43598-0316-05, 43598-0316-30, 43598-0316-60, 43598-0316-90, 43598-0317, 43598-0317-05, 43598-0317-30, 43598-0317-60, 43598-0317-90 and 30 more
Lot numbersC404592
Expiration dates2015-11

Product

Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-318-30) and b) 90 Count Bottles (NDC: 43598-318-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1377-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.